Neurocrine Biosciences
NBIX
#1383
Rank
ยฃ10.09 B
Marketcap
ยฃ99.67
Share price
-0.13%
Change (1 day)
10.55%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): ยฃ1.60

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is ยฃ1.54. In 2022 the company made an earnings per share (EPS) of ยฃ1.26 an increase over its 2021 EPS that were of ยฃ0.75.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.6026.36%
2022ยฃ1.2669.47%
2021ยฃ0.75-78.21%
2020ยฃ3.42990%
2019ยฃ0.3181.82%
2018ยฃ0.17-113.5%
2017-ยฃ1.280.62%
2016-ยฃ1.2757.28%
2015-ยฃ0.8125.61%
2014-ยฃ0.6418.84%
2013-ยฃ0.54-1085.71%
2012ยฃ0.05493-89.71%
2011ยฃ0.53-500%
2010-ยฃ0.13-86.92%
2009-ยฃ1.02-43.48%
2008-ยฃ1.80-57.8%
2007-ยฃ4.2892.58%
2006-ยฃ2.22371.67%
2005-ยฃ0.47-52.76%
2004-ยฃ1.0036.56%
2003-ยฃ0.73-70%
2002-ยฃ2.43118.31%
2001-ยฃ1.118.4%
2000-ยฃ1.0348.86%
1999-ยฃ0.69-20%
1998-ยฃ0.86-479.31%
1997ยฃ0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ยฃ1.64 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.43-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ2.32-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.26 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.89 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.46-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.37-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.38-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA